Related Experiment Video
Updated: Sep 2, 2025

14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.3K
Discontinuation of azacitidine in acute myeloid leukemia: a feasible option?
Anne Boerekamps1, Paul Hamberg2, Eduard J Libourel2
1Department of Internal Medicine, Franciscus Gasthuis and Vlietland Hospital, Kleiweg 500, Rotterdam, 3045 PM, Schiedam, The Netherlands. a.boerekamps@franciscus.nl.
Annals of Hematology
|August 4, 2022
Abstract
No abstract available in PubMed .
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
243
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.6K